Citation Impact
Citing Papers
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Fluorinated nucleosides: Synthesis and biological implication
2008
Gout and hyperuricemia
2002
Higher Levels of CRP, D-dimer, IL-6, and Hyaluronic Acid Before Initiation of Antiretroviral Therapy (ART) Are Associated With Increased Risk of AIDS or Death
2011
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
1992
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells
2004
Treatment triumphs
2014 StandoutNatureNobel
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
2013
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
2006
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
2011
When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries
2011
Pediatric Pulmonary Hypertension
2013
Clevudine: a potent inhibitor of hepatitis B virusin vitroandin vivo
2006
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update*
2003
Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome
2011
Emtricitabine
2003
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Impact of Antiretroviral Therapy and Changes in Virus Load on Human Immunodeficiency Virus (HIV)–Specific T Cell Responses in Primary HIV Infection
2003
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
2015 StandoutNobel
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
1996 Standout
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB
2014
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 Standout
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
1995
Emtricitabine (FTC) for the treatment of HIV infection
2004
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti‐viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
2008
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) in HIV Patients with Culture Confirmed Pulmonary Tuberculosis in India and the Potential Role of IL-6 in Prediction
2013
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
2014
Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
2015 StandoutNobel
MHC ligands and peptide motifs: first listing
1995
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Emtricitabine
2005
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
2008
Diagnosis and Assessment of Pulmonary Arterial Hypertension
2009
HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication
2005
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.
1994 StandoutNobel
Clevudine myopathy in patients with chronic hepatitis B
2009
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician‐ and Patient‐Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS)
2011
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients
2014
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Update on hepatitis C virus resistance to direct-acting antiviral agents
2014
The Metabolic Basis of Pulmonary Arterial Hypertension
2014
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease
1995
Hepatitis C Virus-Specific Directly Acting Antiviral Drugs
2013
Mycobacterial Antigen Driven Activation of CD14++CD16− Monocytes Is a Predictor of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
2014
Emtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B Virus
2005
Immunopathogenesis of Hepatic Flare in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals after the Initiation of HBV‐Active Antiretroviral Therapy
2009
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study
2001
Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1
2014
Cytotoxic T Lymphocytes in Human Immunodeficiency Virus Infection: Responses to Structural Proteins
1994
Type 1 Helper T Cells and FoxP3-positive T Cells in HIV–Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome
2008
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Hypercytokinaemia accompanies HIV–tuberculosis immune reconstitution inflammatory syndrome
2010
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
l-Nucleoside enantiomers as antivirals drugs: A mini-review
2006
Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none
2012
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
2016
TB-IRIS After Initiation of Antiretroviral Therapy Is Associated With Expansion of Preexistent Th1 Responses Against Mycobacterium tuberculosis Antigens
2013
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension
2008
Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
2014
Toxicology of antisense therapeutics
2004
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Elevated Interleukin 8 and T-Helper 1 and T-Helper 17 Cytokine Levels Prior to Antiretroviral Therapy in Participants Who Developed Immune Reconstitution Inflammatory Syndrome During ACTG A5164
2012
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
Current race in the development of DAAs (direct-acting antivirals) against HCV
2014
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis
2010
Corticosteroid-modulated Immune Activation in the Tuberculosis Immune Reconstitution Inflammatory Syndrome
2012
Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
1995
Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection
2001
Fluorine in medicinal chemistry
2007 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein
1992
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis
2019 StandoutNobel
Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
2010
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Cytotoxic T Lymphocyte Epitopes of HIV-1 Nef
2000
Selective expansion of polyfunctional pathogen-specific CD4+ T cells in HIV-1–infected patients with immune reconstitution inflammatory syndrome
2012
Emtricitabine: a new nucleoside analogue for once-daily antiretroviral therapy
2004
Potential Immunocompetence of Proteolytic Fragments Produced by Proteasomes before Evolution of the Vertebrate Immune System
1997 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
1992
Pulmonary Arterial Hypertension
2006
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.
1995 StandoutNobel
In vivo persistence of a HIV‐1‐encoded HLA‐B27‐restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity
1991
Therapeutic Vaccines for Chronic Infections
2004 Science
The Immune Response in Tuberculosis
2013 Standout
Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
2005
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Nucleic-acid therapeutics: basic principles and recent applications
2002
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Polyoxometalates in Medicine
1998 Standout
Broad, Intense Anti-Human Immunodeficiency Virus (HIV) Ex Vivo CD8+Responses in HIV Type 1-Infected Patients: Comparison with Anti-Epstein-Barr Virus Responses and Changes during Antiretroviral Therapy
1999
Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4 + T lymphocytes
2004
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
1993 StandoutNobel
Cardiopulmonary Manifestations of Hepatosplenic Schistosomiasis
2009
Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/ nucleotide inhibitors
2009
Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease
1996
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
2006 StandoutScience
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.
2007
Chemiluminescence Switching on Peroxidase-Like Fe3O4 Nanoparticles for Selective Detection and Simultaneous Determination of Various Pesticides
2012
Works of D. Séréni being referenced
Tuberculosis-Associated Immune Restoration Syndrome in HIV-1-Infected Patients Involves Tuberculin-Specific CD4 Th1 Cells and KIR-Negative γδ T Cells
2009
Evolution of Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus Type 1 in Patients with Symptomatic Primary Infection Receiving Antiretroviral Triple Therapy
1998
Paradoxical exacerbation of tuberculosis after TNFα antagonist discontinuation: Beware of immune reconstitution inflammatory syndrome
2011
Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients
2008
Once‐Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus–Infected Patients
2000
The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C
2011
Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)
2004
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients
2006
An antigenic peptide of the HIV‐1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA‐B
1989
Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once‐daily for the treatment of HIV‐infected adults (pharmacokinetic substudy of the ANRS 091 trial)*
2004
Early Levels of HIV‐1 DNA in Peripheral Blood Mononuclear Cells Are Predictive of Disease Progression Independently of HIV‐1 RNA Levels and CD4+T Cell Counts
2005
Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFNα: results from the Primoferon A (ANRS 086) Study
2001
Impact of pain in health related quality of life of patients with systemic sclerosis
2006
Tenofovir‐Related Nephrotoxicity in Human Immunodeficiency Virus–Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes Insipidus
2003
Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era
2007
Long-term results of monthly inhaled pentamidine as primary prophylaxis of Pneumocystis carinii pneumonia in HIV-infected patients
1993
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B
2004
Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins
1992
Pharmacokinetics and Tolerability of Intravenous Trecovirsen (GEM®91), an Antisense Phosphorothioate Oligonucleotide, in HIV‐Positive Subjects
1999
Highly Active Antiretroviral Treatment Initiated Early in the Course of Symptomatic Primary HIV‐1 Infection: Results of the ANRS 053 Trial
1999
[Attacks of gout and thromboembolic disease: role of heparin therapy].
1985
Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitor
1995
Does transient HAART during primary HIV-1 infection lower the virological set-point?
2004
Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein.
1991